• There are no items in your cart

CLSI MM17 P : 1ED 2007

Superseded

Superseded

A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

View Superseded by

VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS

Superseded date

21-03-2008

Superseded by

CLSI MM17 A : 1ED 2008

Published date

12-01-2013

Sorry this product is not available in your region.

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
   4.1 Definitions
   4.2 Acronyms/Abbreviations
5 Sample Preparation
   5.1 Sample Types
   5.2 Manual Nucleic Acid Extraction
   5.3 Integrity
   5.4 Purity
   5.5 Automated Nucleic Acid Extraction
6 Target Amplification Technologies
   6.1 Target Amplification Technologies
   6.2 Particle-Based Signal Detection Technologies
   6.3 Signal Amplification Technologies
   6.4 Bioelectronic Array Detection of DNA and RNA Hybrids
   6.5 Addressable Microarray
   6.6 Microfluidic Cards
7 Reference and Testing Materials
   7.1 Endogenous Nucleic Acid
   7.2 WGA
   7.3 Nongenomic RMs
   7.4 Internal Controls
8 Analytic Verification and Validation
   8.1 Characterization and Presence of Reagent Components
   8.2 Technical Standard Operating Procedure (TSOP)
   8.3 Software and Algorithms
   8.4 Analytic Validation.
   8.5 Analytic Validation of an LDA
   8.6 Analytic Verification of an IVD
9 Data Analysis and Reporting of Results
   9.1 Types of Tests and Concomitant Data Requirements
   9.2 Genotype Calls
   9.3 Analysis of Analytical Study Results
   9.4 Analysis of Clinical Study Results
   9.5 Possible Limitations
10 Concluding Remarks
References
Additional References and Resources
The Quality Management System Approach
Related CLSI/NCCLS Publications

Provides recommendations for analytic verification and validation of multiplex assays, as well as a review of different types of biologic and synthetic reference materials.

DocumentType
Proposed Guideline
PublisherName
Clinical Laboratory Standards Institute
Status
Superseded
SupersededBy

CLSI EP14 A2 : 2ED 2005 EVALUATION OF MATRIX EFFECTS
CLSI POCT4 A2 : 2ED 2006 POINT-OF-CARE IN VITRO DIAGNOSTIC (IVD) TESTING
CLSI EP12 A : 1ED 2002 USER PROTOCOL FOR EVALUATION OF QUALITATIVE TEST PERFORMANCE
CLSI MM16 A : 1ED 2006 USE OF EXTERNAL RNA CONTROLS IN GENE EXPRESSION ASSAYS
CLSI MM6 A : 1ED 2003 QUANTITATIVE MOLECULAR METHODS FOR INFECTIOUS DISEASES
CLSI EP5 A2 : 2ED 2004 EVALUATION OF PRECISION PERFORMANCE OF QUANTITATIVE MEASUREMENT METHODS
CLSI MM10 A : 1ED 2006 GENOTYPING FOR INFECTIOUS DISEASES: IDENTIFICATION AND CHARACTERIZATION
CLSI GP10 A : 1ED 95(R2001) ASSESSMENT OF THE CLINICAL ACCURACY OF LABORATORY TESTS USING RECEIVER OPERATING CHARACTERISTIC (ROC) PLOTS
CLSI EP6 A : 1ED 2003 EVALUATION OF THE LINEARITY OF QUANTITATIVE MEASUREMENT PROCEDURES - A STATISTICAL APPROACH
CLSI M29 A3 : 3ED 2005 ACQUIRED INFECTIONS; APPROVED GUIDELINE
CLSI EP15 A2 : 2ED 2006 USER VERIFICATION OF PERFORMANCE FOR PRECISION AND TRUENESS
CLSI MM9 A : 1ED 2004 NUCLEIC ACID SEQUENCING METHODS IN DIAGNOSTIC LABORATORY MEDICINE
CLSI MM1 A2 : 2ED 2006 MOLECULAR DIAGNOSTIC METHODS FOR GENETIC DISEASES
CLSI EP17 A : 1ED 2004 PROTOCOLS FOR DETERMINATION OF LIMITS OF DETECTION AND LIMITS OF QUANTITATION
CLSI MM13 A : 1ED 2006 COLLECTION, TRANSPORT, PREPARATION, AND STORAGE OF SPECIMENS FOR MOLECULAR METHODS
CLSI MM12 A : 1ED 2006 DIAGNOSTIC NUCLEIC ACID MICROARRAYS
CLSI EP7 A2 : 2ED 2005 INTERFERENCE TESTING IN CLINICAL CHEMISTRY
CLSI MM3 A2 : 2ED 2006 MOLECULAR DIAGNOSTIC METHODS FOR INFECTIOUS DISEASES
CLSI MM5 A : 1ED 2003 NUCLEIC ACID AMPLIFICATION ASSAYS FOR MOLECULAR HEMATOPATHOLOGY

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.